NIH #5R44CA224848-03
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
- Amount
- $557K
- Period
- 2019-09-18 → 2022-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BIOFLUIDICA, INC